eXoZymes (NASDAQ:EXOZ) Shares Down 4.8% - Here's Why

Key Points

• eXoZymes Inc. (NASDAQ:EXOZ) shares fell by 4.8%, trading at $9.31 after previously closing at $9.78.
• During mid-day trading, the volume of shares traded increased by 139% compared to the average daily volume.
• eXoZymes reported a loss of ($0.28) earnings per share in its latest earnings results released on August 12th.

eXoZymes Inc. (NASDAQ:EXOZ - Get Free Report) shares were down 4.8% during trading on Thursday . The stock traded as low as $9.31 and last traded at $9.31. Approximately 7,776 shares were traded during mid-day trading, an increase of 139% from the average daily volume of 3,258 shares. The stock had previously closed at $9.78.

eXoZymes Trading Down 4.8%

The company has a quick ratio of 6.19, a current ratio of 6.19 and a debt-to-equity ratio of 0.01. The stock's fifty day moving average price is $10.14.

eXoZymes (NASDAQ:EXOZ - Get Free Report) last posted its earnings results on Tuesday, August 12th. The company reported ($0.28) earnings per share for the quarter.

About eXoZymes

eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.